Long-Term Efficacy of Dapagliflozin as Add-On to Metformin (MET) in T2DM Inadequately Controlled with MET Alone

被引：0

|

作者：

Bailey, Clifford J.

Gross, Jorge L.

Yadav, Manoj

Iqbal, Nayyar

Mansfield, Traci A.

List, James F.

机构：

来源：

DIABETES | 2011年 / 60卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

988-P

引用

收藏

页码：A271 / A271

页数：1

相关论文

共 50 条

[1] Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
Toplak, H
Vercruysse, F
Sun, X
Fitchet, M
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 : S159 - S159
[2] Efficacy and Safety of Saxagliptin Add-on to Metformin Compared with Acarbose Add-on to Metformin in Patients with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin Monotherapy
Du, Jin
Liang, Li
Fang, Hui
Xu, Fengmei
Li, Wei
Shen, Liya
Mu, Yiming
DIABETES, 2016, 65 : A293 - A293
[3] Long-Term Efficacy and Safety of Ertugliflozin in Patients (Pts) with Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled with Metformin (MET) Monotherapy-104-Week VERTIS MET Trial
Gallo, Silvina
Charbonnel, Bernard
Goldman, Allison
Shi, Harry
Huyck, Susan
Darekar, Amanda
Lauring, Brett
Terra, Steven
DIABETES, 2018, 67
[4] Dapagliflozin as an add-on to metformin lowers hyperglycaemia in type 2 diabetes patients inadequately controlled with metformin alone
Bailey, C. J.
Gross, J. L.
Bastone, L.
Bastien, A.
List, J. F.
DIABETOLOGIA, 2009, 52 : S76 - S76
[5] Long-term efficacy and safety of add-on dapagliflozin vs add-on glipizide in patients with type 2 diabetes mellitus inadequately controlled with metformin: 2-year results
Del Prato, S.
Nauck, M. A.
Rohwedder, K.
Theuerkauf, A.
Langkilde, A. M.
Parikh, S.
DIABETOLOGIA, 2011, 54 : S348 - S348
[6] Saxagliptin vs Glipizide as Add-On Therapy to Metformin for Type 2 Diabetes Mellitus (T2DM): Long-Term Safety and Efficacy
Goeke, Burkhard
Gallwitz, Baptist
Eriksson, Johan
Bokelund-Singh, Sara
Gause-Nilsson, Ingrid
DIABETES, 2011, 60 : A305 - A305
[7] Add-on to metformin in T2DM—linagliptin or glimepiride?
Mikkel Christensen
Filip K. Knop
Nature Reviews Endocrinology, 2012, 8 : 576 - 578
[8] Economic Evaluation of Dapagliflozin as Add-On to Metformin in T2DM in the Israeli Health Care Setting
Moshel, Shai
Vexberg, Michal Hirsch
Shavit, Oren
Toledano, Yoel
DIABETES, 2018, 67
[9] ECONOMIC EVALUATION OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN FOR T2DM TREATMENT IN THE ISRAELI HEALTHCARE SETTING
Moshel, S.
Vexberg, Hirsch M.
Shavit, O.
Toledano, Y.
VALUE IN HEALTH, 2018, 21 : S131 - S131
[10] Efficacy and Safety of Dapagliflozin in Patients with T2DM Inadequately Controlled on Metformin Plus Sulfonylureas According to Background Sulfonylurea
Matthaei, Stephan
Bowering, Keith
Rohwedder, Katja
Grohl, Anke
Johnsson, Eva
DIABETES, 2015, 64 : A332 - A332

← 1 2 3 4 5 →